| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;48:157.)
© 2006 American Heart Association, Inc.
Original Articles |
From the Hypertension and Vascular Research Division (M.H., N.J.H., J.L.G.), Henry Ford Hospital, Detroit, Mich, and Department of Physiology (J.L.G.), Wayne State University, Detroit, Mich.
Correspondence to Jeffrey L. Garvin, PhD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202. E-mail jgarvin1{at}hfhs.org
NO plays a role in the regulation of blood pressure through its effects on renal, cardiovascular, and central nervous system function. It is generally thought to freely diffuse through cell membranes without need for a specific transporter. The water channel aquaporin-1 transports low molecular weight gases in addition to water and is expressed in cells that produce or are the targets of NO. Consequently, we tested the hypothesis that aquaporin-1 transports NO. In cells expressing aquaporin-1, NO permeability correlated with water permeability. NO transport was reduced by 71% by HgCl2, an inhibitor of aquaporin-1. Transport of NO by aquaporin-1 saturated at 3 µmol/L NO and displayed a K1/2 (the concentration of NO that produces half of the maximum transport rate) of 0.54 µmol/L. Reconstitution of purified aquaporin-1 into lipid vesicles increased NO influx by 316%. In endothelial cells, lowering aquaporin-1 expression with a small interfering RNA (siRNA) blunted aquaporin-1 expression by 54% and NO release by 44%. We conclude that NO transport by aquaporin-1 may allow cells to control intracellular NO levels and effects. NO transport by aquaporin-1 may play a role in central nervous system, vascular and renal function, and consequently blood pressure. Disruption of NO transport by aquaporin-1 offers an alternate cause for diseases currently explained by inadequate NO bioavailability.
Key Words: nitric oxide
Related Article:
Hypertension 2006 48: 29-30.
This article has been cited by other articles:
![]() |
J. C. Mathai, A. Missner, P. Kugler, S. M. Saparov, M. L. Zeidel, J. K. Lee, and P. Pohl No facilitator required for membrane transport of hydrogen sulfide PNAS, September 29, 2009; 106(39): 16633 - 16638. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Musa-Aziz, L.-M. Chen, M. F. Pelletier, and W. F. Boron Relative CO2/NH3 selectivities of AQP1, AQP4, AQP5, AmtB, and RhAG PNAS, March 31, 2009; 106(13): 5406 - 5411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hub and B. L. de Groot Mechanism of selectivity in aquaporins and aquaglyceroporins PNAS, January 29, 2008; 105(4): 1198 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Echevarria, A. M. Munoz-Cabello, R. Sanchez-Silva, J. J. Toledo-Aral, and J. Lopez-Barneo Development of Cytosolic Hypoxia and Hypoxia-inducible Factor Stabilization Are Facilitated by Aquaporin-1 Expression J. Biol. Chem., October 12, 2007; 282(41): 30207 - 30215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin Novel role of AQP-1 in NO-dependent vasorelaxation Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1443 - F1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Kone NO Break-Ins at Water Gate Hypertension, July 1, 2006; 48(1): 29 - 30. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |